Visualize HL7 Example and Test Instances (vi7eti), pronounced /viːˈsɛtiː/
Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on medicines. The web pages are not kept up to date and are for demonstration purposes only. For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine.
 BACK TO LIST

European Patient Summary

Patient
Name: Smith, , Timothy,
DOB: 10-SEP-1941 (Age: 84)
Gender: male
ID: 8029-862360-6 (ECI)
Author
Dr. Ping, Hel
Patient summary Document
European Patient Summary
Report Date: 19-MAY-2025

Problem list

Condition Onset Date Status
Chronic congestive heart failure 01-Jul-2024 active
Aortic valve stenosis 09-May-2015 active
Ischemic heart disease 20-Oct-2008 active
Osteoporosis 04-Sep-2000 active
Dependent drug abuse 22-Mar-1996 active
Hyperlipidemia 01-Aug-1994 active
Obstructive sleep apnea syndrome 26-May-1992 active
Sleep disorder 14-May-1992 active
Acute non-ST segment elevation myocardial infarction 30-Apr-1991 active
Chronic intractable migraine without aura 09-Aug-1990 active
Impacted molars 27-May-1990 active
Essential hypertension 22-Jun-1987 active
Hyperglycemia 22-Jun-1987 active
Metabolic syndrome X 22-Jun-1987 active
Hypertriglyceridemia 22-Jun-1987 active
Type 2 diabetes mellitus 16-Jun-1986 active
Anemia 21-Feb-1983 active
Prediabetes 07-Jun-1982 active

Medication list

Medication Since Form Dosage Reason
Carvedilol 25 mg oral tablet 2025-05-19 - 1 tablet (25 mg) by mouth twice daily Chronic congestive heart failure (disorder)
Amlodipine (as amlodipine besylate) 2.5 mg oral tablet 2025-05-19 - 1 tablet (2.5 mg) by mouth once daily Essential hypertension (disorder)
Hydrochlorothiazide 25 mg oral tablet 2025-05-19 - 1 tablet (25 mg) by mouth once daily Essential hypertension (disorder)
Furosemide 40 mg oral tablet 2025-05-19 - 1 tablet (40 mg) by mouth once daily Chronic congestive heart failure (disorder)
Lisinopril 20 mg oral tablet 2025-05-19 - 1 tablet (20 mg) by mouth once daily Chronic congestive heart failure (disorder)
Metformin hydrochloride 500 mg prolonged-release oral tablet 2025-05-19 - 1 tablet (500 mg) once daily Diabetes mellitus type 2 (disorder)
Alendronic acid (as alendronate sodium) 10 mg oral tablet 2025-05-19 - 1 tablet (10 mg) once daily Osteoporosis (disorder)
Simvastatin 10 mg oral tablet 2025-02-03 - 1 tablet (10 mg) by mouth once daily Hyperlipidemia
Clopidogrel (as clopidogrel bisulfate) 75 mg oral tablet 2008-10-27 - 1 tablet (75 mg) once daily -
Simvastatin 20 mg oral tablet 2008-10-27 - 1 tablet (20 mg) once daily -
Nitroglycerin 400 microgram/actuation sublingual spray 2008-10-27 - 400 micrograms per spray, use 1 spray under the tongue as needed for chest pain, may repeat every 5 minutes as needed, up to 3 sprays in 15 minutes -
Metoprolol tartrate (as metoprolol succinate) 100 mg prolonged-release oral tablet 2008-10-27 - 1 tablet (100 mg) once daily -
Aspirin 81 mg gastro-resistant oral tablet 1991-05-02 - 1 tablet (81 mg) by mouth once daily -
Atorvastatin (as atorvastatin calcium) 20 mg oral tablet 1991-05-02 - 1 tablet (20 mg) by mouth once daily -
Prasugrel (as prasugrel hydrochloride) 10 mg oral tablet 1991-05-02 - 1 tablet (10 mg) once daily -
Metoprolol tartrate (as metoprolol succinate) 50 mg prolonged-release oral tablet 1991-05-02 - 1 tablet (50 mg) once daily -
Losartan potassium 100 mg oral tablet 1991-05-02 - 1 tablet (100 mg) by mouth once daily -

Immunizations list

Vaccine Date
Influenza virus antigen only vaccine product 20-Jan-2025
Clostridium tetani toxoid antigen adsorbed only vaccine product 16-Aug-2021
SARS-CoV-2 mRNA vaccine 22-Feb-2021

Procedure History list

Procedure Date Reason
Patient discharge 25-Jun-2025 -
Hospice care 24-Jun-2025 -
Notifications 09-Jun-2025 -
Certification procedure 09-Jun-2025 -
Initial patient assessment 09-Jun-2025 -
Development of individualized plan of care 09-Jun-2025 -
Sleep apnea assessment 19-May-2025 Sleep disorder (disorder)
Depression screening 19-May-2025 -
Assessment of health and social care needs 19-May-2025 -
Assessment using Morse Fall Scale 19-May-2025 -
Screening for domestic abuse 19-May-2025 -
Depression screening using Patient Health Questionnaire Two-Item score (procedure) 19-May-2025 -
Heart failure education 31-Jan-2025 Chronic congestive heart failure (disorder)
Oxygen administration by mask 30-Jan-2025 -
Placing subject in prone position 30-Jan-2025 -
Electrocardiographic procedure 27-Jan-2025 Chronic congestive heart failure (disorder)
Echocardiography 27-Jan-2025 -
Plain X-ray of chest 27-Jan-2025 -
Medication reconciliation 27-Jan-2025 -
Assessment of anxiety 25-Jun-2018 -
History AND physical examination 18-Jan-2016 Aortic valve stenosis (disorder)
Operative procedure planned 18-Jan-2016 Aortic valve stenosis (disorder)
Referral to cardiac surgery service 18-Jan-2016 Aortic valve stenosis (disorder)
Review of imaging finding (procedure) 18-Jan-2016 Aortic valve stenosis (disorder)

Allergies and Intolerances

Allergy/Intolerance Onset Date Status Type Reaction
? active ?

Care Plan

Active Planned Care / Goals Start Date Reason
Heart failure self management plan 17-Jul-2024 Chronic congestive heart failure (disorder)
  • Patient will monitor and record weight daily to detect early signs of fluid retention.
  • Patient will limit sodium intake to less than 2 grams per day.
  • Patient will restrict daily fluid intake as recommended.
  • Patient will take all heart failure medications as prescribed without missing doses.
  • Patient will recognize and promptly report symptoms such as increased shortness of breath, swelling, or rapid weight gain.
Hyperlipidemia clinical management plan 22-Aug-1994 Hyperlipidemia
  • Achieve LDL cholesterol less than 1.8 mmol/L for secondary prevention of atherosclerotic cardiovascular disease
  • Achieve non-HDL cholesterol less than 2.6 mmol/L
  • Achieve fasting triglycerides less than 1.7 mmol/L
Care plan 26-May-1992 Obstructive sleep apnea syndrome (disorder)
  • Achieve weight loss to reduce severity of obstructive sleep apnea.
  • Reduce AHI to less than 15 events per hour.
  • Use CPAP device for at least 4 hours per night on 70% of nights.
  • Maintain minimum nocturnal oxygen saturation above 90%.
Discharge care plan 02-May-1991 -
Lifestyle education regarding hypertension 22-Jun-1987 Essential hypertension (disorder)
  • Patient will implement recommended lifestyle changes to achieve and maintain target blood pressure.
Diabetes self management plan 07-Jun-1982 Prediabetes
  • Patient will achieve and maintain target HbA1c through diabetes self-management strategies.
  • Patient will achieve and maintain fasting blood glucose within target range through diabetes self-management strategies.
  • Patient will achieve and maintain target body weight as part of diabetes self-management.
Immunization Recommendation Due Date Reason
Vaccine product containing only Influenza virus antigen (medicinal product) 01-Oct-2025 Annual seasonal influenza vaccination

Vital Signs

Vital Signs 2025-05-19 2025-01-31
Body Height 172.5 cm -
Pain severity - 0-10 verbal numeric rating [Score] - Reported 1 {score} -
Body Weight 83.1 kg 83.1 kg
Body mass index (BMI) [Ratio] 27.9 kg/m2 -
Diastolic Blood Pressure 44 mm[Hg] -
Systolic Blood Pressure 78 mm[Hg] -
Heart rate 62 /min -
Respiratory rate 13 /min -

Relevant diagnostic tests/laboratory data

Recent Lab Observations 19-MAY-2025 Reference Range Unit
Hemoglobin A1c/Hemoglobin.total in Blood 5.5 4.5 - 6.4 %
Glucose [Mass/volume] in Blood 131.1 70 - 140 mg/dL
Urea nitrogen [Mass/volume] in Blood 19.6 7 - 25 mg/dL
Creatinine [Mass/volume] in Blood 0.7 0.6 - 1.3 mg/dL
Calcium [Mass/volume] in Blood 9.1 8.5 - 10.5 mg/dL
Sodium [Moles/volume] in Blood 143.9 135 - 145 mmol/L
Potassium [Moles/volume] in Blood 4.7 3.5 - 5.1 mmol/L
Chloride [Moles/volume] in Blood 102.9 98 - 107 mmol/L
Carbon dioxide, total [Moles/volume] in Blood 26.5 22 - 29 mmol/L
Cholesterol [Mass/volume] in Serum or Plasma 244.9 H 0 - 200 mg/dL
Triglyceride [Mass/volume] in Serum or Plasma 490.0 H 0 - 199 mg/dL
Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay 119.1 0 - 130 mg/dL
Cholesterol in HDL [Mass/volume] in Serum or Plasma 27.8 L 40 - 100 mg/dL
Microalbumin/Creatinine [Mass Ratio] in Urine 14.7 0 - 30 mg/g

Device Use

Device Date (since)
Home continuous positive airway pressure unit (physical object) 19-May-2025
Respiratory humidifier (physical object) 19-May-2025
Blood glucose meter (physical object) 07-Jun-1982